For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses.
Scope of the Report:
Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years.
The global Sexually Transmitted Disease (STD) Diagnosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexually Transmitted Disease (STD) Diagnosis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Sexually Transmitted Disease (STD) Diagnosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexually Transmitted Disease (STD) Diagnosis market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Thermo Fisher Scientific
- BCR Diagnostics
- BD Medical
- GenMark Diagnostics
- OraSure Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Chlamydia testing
- Syphilis testing
- Gonorrhoea testing
- Herpes simplex virus testing
- Human papilloma virus testing
- Human immunodeficiency virus testing
Market Segment by Applications, can be divided into
- Government organizations
- Diagnostic clinics